Prognostic and predictive factors in lung cancer

Symposium
Chairs: A.-P. Meert (Brussels, Belgium), N. Schoenfeld (Berlin, Germany)
Aims: The audience will improve its knowledge about the role of these prognostic and predictive factors, how they can predict survival, how to identify patients who will benefit from some specific treatment and how to validate such markers in clinical practice.

Independent prognostic factors and prognostic classifications: how can we predict survival on the basis of clinical, pathological and routine biological factors? E. Quoix (Strasbourg, France)
Predictive factors: can we identify patients who will benefit from a specific treatment? M. Tsao (Toronto, Canada)
How can we validate a predictive factor and bring it into clinical practice? M. Paesmans (Brussels, Belgium)